A randomised controlled trial investigating the sensitivity and specificity of a single-use saliva based drug test in detecting two doses of orally admistered delta-9 tetrahydrocannabinol (THC) oil and the effect on driving performance

Swinburne University of Techology0 个研究点目标入组 40 人开始时间: 2016年2月29日最近更新: 2020年1月13日

试验速览

暂无简介。

•Aged between 21 and 55 years
•2. Hold a full drivers licence (no ‘P’ plates)
•3. Participants will also be required to have experimented with cannaboids previously (self-disclosure).
•4 Have no history of past substance abuse or current abuse of illicit drugs
•5. Have no pre-existing physical or neurological conditions, no previous or current history of severe psychiatric, cardiac, endocrine, gastrointestinal, or bleeding disorders
•6. Not currently pregnant or lactating

•1. Inability to speak or read English
•2. History of drug or substance abuse or current illicit drug abuse
•3. History of neurological conditions or previous or current history of psychiatric, cardiac, endocrine, gastrointestinal, or bleeding disorders
•4 Taking any form of medication within 5 days of admission (except for prophylactic antibiotics, or other routine medications to treat benign conditions, such as antibiotics to treat acne) and agree not to take any medication throughout the study
•5. Current participation in any other trials involving investigational or marketed products within 30 days prior to the screening visit
•6. Unable to participate in all scheduled visits, treatment plan, tests and other trial procedures according to the protocol
•7. Unable to provide a personally signed and dated informed consent indicating that the subject has been informed of all pertinent aspects of the trial.

发起方

Swinburne University of Techology